期刊文献+

多西紫杉醇PLGA/nHA复合微球的制备及体外释放研究 被引量:4

Preparation and in vitro release of Docetaxel loaded PLGA/nHA microspheres
暂未订购
导出
摘要 目的制备多西紫杉醇(DTX)聚乳酸羟基乙酸(PLGA)/纳米羟基磷灰石(nHA)复合微球,研究纳米羟基磷灰石对复合微球的载药量,包封率和体外释放等性质的影响,以及抑制前列腺癌细胞的增长效应。方法以疏水性抗癌药物多西紫杉醇作为模型药物,采用单乳化溶剂挥发法(S/O/W)制备PLGA/nHA-DTX复合微球,对载药前后的纳米羟基磷灰石进行透射电子显微镜观察和FTIR分析,并采用扫描电镜、激光粒度仪和高效液相色谱对微球的载药量、包封率、粒径及体外释药性质进行研究。结果FTIR结果表明纳米羟基磷灰石对多西紫杉醇有较强的吸附作用。PLGA/nHA-DTX复合微球的载药量和包封率分别为3.92%和88.7%,较之单纯的PLGA-DTX微球均有很大的提高。经过体外释放药物突释后,复合微球比单纯PLGA微球的药物释放慢。在第30d时,复合微球和单纯的PLGA微球累积药物释率放分别为62.40%和72.70%。MTT实验结果显示PLGA/nHA复合微球对癌细胞增长的抑制效果优于单纯PLGA微球和药物。结论与单纯的PLGA-DTX微球相比,由于纳米羟基磷灰石对多西紫杉醇存在较强的吸附作用,使PLGA/nHA-DTX复合微球的载药量和包封率得到了较大的提高,具有更好的药物缓释效果,抑制癌细胞增长的作用更有效。 [ Objectives] To prepare docetaxel (DTX) loaded PLGA/nHA microspheres, research the effect of nHA on drug loading, encapsulation efficiency, in vitro of composite mierospheres and inhibiting the growth of prostate cancers. [ Method ] PLGA/nHA-DTX composite microspheres were prepared by a single-emulsion solvent evaporation method (S/O/W), with hydrophobie anticaneer doeetaxel as model drug. nHA and drug-loaded nHA were analyzed by TEM and FTIR, and drug loading, encapsulation efficiency, size and in vitro release of mierospheres were studied with SEM, laser particle size analyzer and HPLC, etc. [Results] The results show that nHA have a strong adsorption with DTX. Drug loading and encapsulation efficiency of PLGA/nHA-DTX composite mierospheres were 3.92% and 88.7%, and have greatly improved compared to neat PLGA-DTX microspheres. After initial burst, composite mierospheres released more slowly than neat PLGA mierospheres. At the 30d after in vitro release, the cumulative release rate of composite mierospheres and neat PLGA microspheres were respectively 62.40% and 72.70%. Cytotoxicity test results showed that PLGA/nHA composite microspheres had better effect than PLGA microspheres and DTX to inhibit cancer cell growth. [ Conclusion ] Because nHA has a strong adsorption with DTX, PLGA/nHA-DTX composite microspheres compared to neat PLGA-DTX microspheres enhance drug loading and encapsulation efficiency, and have better drug delivery effect. The effect of inhibiting the growth of cancers of the composite microspheres is also better.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第19期2946-2950,共5页 China Journal of Modern Medicine
基金 中国高新技术计划(No:2007AA021807) (No:2007AA021908) 中国自然科学基金重点项目(No:50732003)
关键词 多西紫杉醇 乳酸-羟基乙酸共聚物 羟基磷灰石 复合微球 药物释放 Docetaxel PLGA hydroxyapatite composite microsphere drug delivery
  • 相关文献

参考文献22

  • 1李高峰,李桂生,宁四海.国产多烯紫杉醇及联合顺铂治疗非小细胞肺癌临床研究[J].中国医学工程,2005,13(6):622-625. 被引量:4
  • 2唐丽萍,徐向英,马荣,韩毅敏,于丽波.多西紫杉醇对宫颈癌细胞系Hela细胞毒性和放射增敏作用的研究[J].中国现代医学杂志,2006,16(16):2419-2422. 被引量:8
  • 3HO-YOUNG HWANG, IN-SAN KIM, ICK CHAN KWON, et al. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol ehitosan nanopartieles [J]. Journal of Controlled Release, 2008, 128: 23-31.
  • 4MUSUMECIA T, VENTURA CA, GIANNONE I, et al. PLA/PLGA nanoparticles for sustained release of docetaxel [J]. International Journal of Pharmaceutics, 2006, 325: 172-179.
  • 5SANTOS C, MARTINS MAI FRANKE RP, et al. Calcium phosphate granules for use as a 5-Fluorouracil delivery system[J]. Ceramics International, 2009, 35: 1587-1594.
  • 6COSHNSA A, VERVAET C, LUYTEN J, et al. Porous hydroxyapatite tablets as carriers for low-dosed drugs [J]. European Journal of Pharmaceutics and Biopharmaceutics, 2007, 67: 498-506.
  • 7FAN J, LEI J, YU CZ, et al. Hard-templating synthesis of a novel rod-hke nanoporous calcium phosphate bioceramics and their capacity as antibiotic carriers [J]. Materials Chemistry and Physics, 2007, 103: 489-493.
  • 8TSE-YING LIU A, SAN-YUAN CHEN, DEAN-MO LIU, et al. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery[J]. Journal of Controlled Release, 2005, 107:112-121.
  • 9KIM HW, KNOWLES JC, KIM HE. Hydroxyapatite/poly(-caprolactone) composite coatings on hydroxyapafite porous bone scaffold for drug delivery[J]. Biomaterials, 2004, 25: 1279-1287.
  • 10KIM HW, LEE SY, BAE C J, et al. Porous ZrO2 bone scaffold coated with hydroxyapatite with fluorapatite intermediate layer[J].Biomaterials, 2003, 24: 3277-3284.

二级参考文献15

共引文献10

同被引文献76

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部